Supportive and palliative care in hemato-oncology: how best to achieve seamless integration and subspecialty development? Hon Wai Benjamin ChengKa On Lam Review Article 03 January 2021 Pages: 601 - 606
Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy Henu Kumar VermaYashwant Kumar RatreRaffaella Colombatti Review Article 04 January 2021 Pages: 607 - 614
Skin changes in hairy cell leukemia Ewa RobakDorota Jesionek-KupnickaTadeusz Robak Review Article Open access 20 November 2020 Pages: 615 - 625
The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with β-thalassemia intermedia: a randomized double-blind clinical trial Mohammadreza SaeidniaPeyman Nowrouzi-SohrabiMehran Karimi Original Article 12 January 2021 Pages: 627 - 633
Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia Sezaneh HaghpanahNader CohanOmid Reza Zekavat Original Article 20 November 2020 Pages: 635 - 644
Risk factors and predictors of treatment responses and complications in immune thrombocytopenia Shin Yeu OngChuen Wen TanLai Heng Lee Original Article 30 January 2021 Pages: 645 - 651
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis Simona RasoMariasanta NapolitanoSergio Siragusa Original Article 26 January 2021 Pages: 653 - 659
Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes Ronak H. MistryAndrew KohutPatricia Ford Original Article 09 November 2020 Pages: 661 - 666
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg? Jihad G. YoussefFaisal ZahiruddinSwaminathan P. Iyer Original Article 13 January 2021 Pages: 667 - 673
Hematologic changes predict clinical outcome in recovered patients with COVID-19 Jian MaoRong DaiXiao-Hua Luo Original Article 01 February 2021 Pages: 675 - 689
Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma Liudmila V. FedorovaKirill V. LepikBoris V. Afanasyev Original Article 02 February 2021 Pages: 691 - 698
Acute lymphoblastic leukemia–like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients Eman O. RasekhRanda OsmanSally Elfishawi Original Article 23 November 2020 Pages: 699 - 707
Watch-and-wait or immediate immunotherapy/immunochemotherapy in patients with phase IE primary pulmonary MALT lymphoma? A multicenter retrospective study Wei YanBin WuHui-Han Wang Original Article 22 January 2021 Pages: 709 - 714
Novel tumour–infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma Qiqi ZhuXueqin DengSha Zhao Original Article 02 January 2021 Pages: 715 - 723
Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis Leonardo Javier ArcuriAndre Dias Americo Original Article 11 January 2021 Pages: 725 - 734
Utilization of radiation therapy in multiple myeloma: trends and changes in practice Sikander AilawadhiRyan FrankTaimur Sher Original Article 12 January 2021 Pages: 735 - 741
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin Tetsuya NishidaTakeshi KobayashiMakoto Murata Original Article 11 January 2021 Pages: 743 - 752
Possible nosocomial transmission of virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation Yoshiyuki OndaJunya KandaAkifumi Takaori-Kondo Original Article 13 January 2021 Pages: 753 - 761
Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis Michalina KołodziejczakLidia Gilon behalf of Infectious Diseases Working Party, European Society for Blood and Marrow Transplantation Original Article Open access 25 January 2021 Pages: 763 - 777
Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis Tobias WertheimerMarius DohseDaniel Wolff Original Article Open access 30 January 2021 Pages: 779 - 787
Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level Warren FingrutArjun LawDennis Dong Hwan Kim Original Article 07 January 2021 Pages: 789 - 798
Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study Wen-Jing YuYu-Qian SunYu Wang Original Article 08 January 2021 Pages: 799 - 808
Early autologous and allogeneic peripheral blood stem cell transplantation for adult patients with acute B and T cell precursor neoplasms: a 12-year single center experience Normann SteinerL. BrunelliD. Nachbaur Original Article Open access 26 January 2021 Pages: 809 - 816
Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial Odelia AmitYael Bar OnRon Ram Original Article 13 January 2021 Pages: 817 - 824
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative Francesc BoschBlanca NavarroMaría José Terol Original Article Open access 06 January 2021 Pages: 825 - 830
A rare cause of respiratory failure in acute myeloid leukaemia patient F. Z. LahlimiI. Tazi Letter to the Editor 14 July 2020 Pages: 831 - 832
Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19 Guido LancmanBridget K. MarcellinoKevin Troy Letter to the Editor 01 August 2020 Pages: 833 - 835
Compassionate use of glasdegib in combination with low-dose cytarabine for relapsed, refractory acute myeloid leukemia or high-risk myelodysplastic syndrome Márcio TavaresSérgio ChacimJosé Mário Mariz Letter to the Editor 01 October 2020 Pages: 837 - 839
Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report Hannah SchüllerFranziska KleinEric Peter Prager Letter to the Editor Open access 10 November 2020 Pages: 841 - 842
COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan Xiang ZhouTao BaiLeo Rasche Letter to the Editor Open access 18 July 2020 Pages: 843 - 846
Repeated ruptures of corpus luteum in a female patient with alpha1-antitrypsin Pittsburgh Xiao-Hua LuoYan ZhuLin Liu Letter to the Editor 06 November 2020 Pages: 847 - 850
Ixazomib and lenalidomide maintenance therapy in multiple myeloma Ricardo D. ParrondoVictoria AlegriaSikander Ailawadhi Letter to the Editor 08 November 2020 Pages: 851 - 853